Company Filing History:
Years Active: 2010-2013
Title: Innovations by Shankar Sanganabhatla: A Glimpse into His Contributions
Introduction
Shankar Sanganabhatla is an accomplished inventor based in Navi Mumbai, India, known for his significant contributions to pharmaceutical sciences. With two patents to his name, he has made remarkable strides in developing innovative drug formulations.
Latest Patents
His latest patents include:
1. **Amorphous Bupropion Hydrobromide and Preparation Thereof**: This invention provides an amorphous form of bupropion hydrobromide along with granulates that contain at least one pharmaceutically acceptable carrier, detailing the process for its preparation.
2. **Carvedilol Dihydrogen Phosphate Monohydrate**: This patent discloses a crystalline form of carvedilol dihydrogen phosphate monohydrate, characterized by high aqueous solubility. The patent also details a method for its preparation and applications for treating hypertension, congestive heart failure, and angina in mammals.
Career Highlights
Shankar has built his career at reputable companies in the pharmaceutical industry, including Wanbury Limited and Glenmark Generics Limited. His experience has equipped him with a diverse skill set in drug development and formulation.
Collaborations
Throughout his career, Shankar has worked alongside talented coworkers such as Sunanda Manoj and Ramanarasimha Moorthy Koduru. These collaborations have likely contributed to his innovative approaches and successes in the field.
Conclusion
Shankar Sanganabhatla's work exemplifies the spirit of innovation in pharmaceutical research. His patents serve as a testament to his dedication to advancing healthcare solutions, and his contributions have undoubtedly impacted the field significantly.